Lyme Disease Testing

General

Synonym/Acronym:
N/A

Rationale
To detect antibodies to the organism that causes Lyme disease.

Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction.

Normal Findings
(Method: Enzyme immunoassay [EIA]) Negative; positives are confirmed either by an FDA approved EIA test that has been cleared for use in the serodiagnosis of Lyme disease or by Western blot analysis (immunoblot). The criterion for interpretation of a positive immunoblot test requires the identification of at least five specific bands.

Critical Findings and Potential Interventions
Specific infectious organisms are required to be reported to local, state, and national departments of health. Lists of specific organisms may vary among facilities. State health departments provide information regarding reportable diseases, which can be accessed at each state health department Web site. The CDC provides information regarding national notifiable diseases at https://ndc.services.cdc.gov /search-results-year/.

There's more to see -- the rest of this topic is available only to subscribers.